The Pillarsetty Lab @ MSK

We are a research group at @MSKCancerCenter. We develop tools to image and treat cancer and other human diseases.

All opinions are our own.

[Itai Yanai @ItaiYanai]

There are ~40k postdocs in the US, according to the NIH. While PhD students generally have good support (their committees, external advisors, and classmates), the postdocs do not. To help with this, we're starting the 'Postdoc Night Science' club with a first branch in NYC. ⬇️

[Chenxin Li, PhD (@chenxinli2.bsky.social) @ChenxinLi2]

Good stuff!

[The Pillarsetty Lab @ MSK @PillarsettyLab]

@radiochemivis Sorry to hear that Ivis. Hoping that it is the mildest form. Sending hope, strength and support your way.

[The Pillarsetty Lab @ MSK @PillarsettyLab]

@maur3ra @UniLeipzig @HZDR_Dresden Congratulations Andreas.

[Jason Lewis Radiochem MSK @LewisLabMSKCC]

Thank you @MSKEducation for the Fun Fund! got to spend a lovely afternoon in Central Park with Fried Chicken and all the sides! Our annual Z20 picnic. @LewisLabMSKCC @KeshariLab @grimmrad @PillarsettyLab

[The Pillarsetty Lab @ MSK @PillarsettyLab]

Proud of this amazing & collaborative effort in imaging NEPC & AR- prostate cancers with @LewisLabMSKCC & @samirzaidi labs. Congrats to @ImbertiCinzia for leading the work & Josh Korsen (former Lewis Lab graduate) for initiating the work & all authors for their contribution.

[Jason Lewis Radiochem MSK @LewisLabMSKCC]

Read our latest "CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer" in the JNM lead by postdoc alumni @ImbertiCinzia and with @PillarsettyLab @samirzaidi labs https://t.co/euFCBzjYnx

[Tim Witney @TimWitney]

New paper out in #npjImaging @Nature_NPJ!

'Fast histological assessment of adipose tissue inflammation by label-free mid-infrared optoacoustic microscopy' from @MunichImaging.

Read the paper here: https://t.co/QJBqsU5LNp

[JNM @JournalofNucMed]

Unraveling the impact of ¹⁷⁷Lu-PSMA radioligand therapy on renal impairment: Distinguishing causation from correlation. https://t.co/fUUempwvkG

#RPTherapy #NuclearMedicine #ProstateCancer @DrMHofman

[Jason Lewis Radiochem MSK @LewisLabMSKCC]

World meet Dr. Kyeara Mack! @KyearaMack @LewisLabMSKCC

[The Pillarsetty Lab @ MSK @PillarsettyLab]

☢️ This @JournalofNucMed paper describes the use of anti-glypican mAbs for imaging and treatment of pancreatic ductal adenocarcinoma via alpha-emitter radiotherapy. PDAC is among the most deadly cancers, and new treatments are urgently needed. —E.S.

https://t.co/z6icifsVI5

[The Pillarsetty Lab @ MSK @PillarsettyLab]

Non-cancerous cells were unaffected. But, it is yet unknown whether this or similar methods could be effective in vivo. If so, manipulation of bioelectrical signaling processes via quantum tunneling could eventually form the basis for a new family of cancer therapeutics. —E.S.

[The Pillarsetty Lab @ MSK @PillarsettyLab]

⚡This @NatureNano study described a unique method to initiate #cancer cell #apoptosis using electron transfer via #quantum biological tunneling. A nanoscale "antenna" conjugated to Cyt-c in combination with an electric field killed GBM cells in vitro.

https://t.co/JpxrNzE2mf

[Jason Lewis Radiochem MSK @LewisLabMSKCC]

Huge congratulations to Dr Ben McLarney @McLarney_PhD on his new paper out in JNM “Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via pHLIP-ICG” @LewisLabMSKCC @grimmrad @PillarsettyLab @HellerLab https://t.co/sJUz4Qtma1

[Chiosis Lab @chiosislabmskcc]

Check out our publication in @Biomedicines_MDPI and Discover the secret behind prolonged drug action! @chiosislabmskcc @Pillarsettylab @MSKCancerCenter research on epichaperome agents zelavespib and icapamespib sheds light on their efficacy.
https://t.co/ynq0xO3xQv

[The Pillarsetty Lab @ MSK @PillarsettyLab]

Excited to attend @WMISWMIC 2023 in Prague to learn about new discoveries & share our work. Talks & posters from lab members Kali, @paulademetrio09, Rachel,@ArtschwagerRaik @RMExner, Teja, Tullio, Vilma, Zelie, & collaborative work from @ECharlesPratt @McLarney_PhD & @Tendler_S

[The Pillarsetty Lab @ MSK @PillarsettyLab]

Unlike uptake mechanisms like the "EPR effect", nanoparticle exit from tumors has been inadequately studied. Tumor retention is at least partially determined by exit in addition to uptake, and this knowledge will help us improve nanoparticles for #cancer #theranostics.

—E. S.

[The Pillarsetty Lab @ MSK @PillarsettyLab]

🔬 Interesting @NatureMaterials paper delves into the exit mechanisms of #nanoparticles from solid #tumors, finding clearance to be size dependent and mostly thru the lymphatic system. Very few particles diffuse directly back into the blood.

https://t.co/LHnWLVPnLv

[The Pillarsetty Lab @ MSK @PillarsettyLab]

We had a good time with fellow 20th floor lab members despite our Spot Sheep Meadow being closed.

[Jason Lewis Radiochem MSK @LewisLabMSKCC]

Annual picnic for Z20 in Central Park and a goodbye to our amazing undergrad and high school summer students. @MSKEducation @PillarsettyLab @Vladimi78819357 @grimmrad @TheZeglisLab @KeshariLab @LewisLabMSKCC @AnLab_MSKCC

[The Pillarsetty Lab @ MSK @PillarsettyLab]

MISP 2023 fellow Audrey Luo @audreysluo presented her research project conducted under the guidance of Raik @ArtschwagerRaik. Absolutely delighted to have her & impressed by her knowledge & diligence. Thanks to Raik for his mentorship, @MSKEducation & Cheung family for support.

[The Pillarsetty Lab @ MSK @PillarsettyLab]

Proud of our own @ArtschwagerRaik being recognized by @SNM_MI as “Ones to Watch” in 2023. Congratulations Raik.

[SNMMI @SNM_MI]

SNMMI is pleased to announce our annual list of early career professionals selected as “Ones to Watch” in 2023. We are proud to showcase rising talent in the field, offering a platform to increase recognition for early career professionals within our specialty. Congratulations!